respiratori
system
consid
among
import
system
human
bodi
respiratori
system
divid
three
complet
differ
region
differ
anatom
unit
primari
region
refer
head
airway
region
second
lung
airway
third
region
alveolar
one
inhal
particl
enter
respiratori
system
inhal
process
deposit
one
region
sever
microorgan
virus
addit
deposit
initi
differ
type
respiratori
diseas
tu
et
al
unfortun
throughout
year
sever
critic
lethal
diseas
complic
develop
would
effect
import
system
inflict
import
health
issu
reciproc
reduc
qualiti
life
work
product
increas
morbid
mortal
burden
respiratori
disord
caus
immens
worldwid
health
burden
estim
million
peopl
suffer
asthma
goetz
singh
studi
address
less
million
peopl
suffer
chronic
obstruct
pulmonari
diseas
copd
huge
number
million
experi
moderatetosever
copd
million
adult
popul
endur
sleepdisord
breath
million
fight
occup
lung
diseas
million
adult
popul
live
pulmonari
hypertens
million
peopl
develop
tuberculosi
annual
total
number
billion
peopl
suffer
chronic
respiratori
condit
hand
least
billion
peopl
expos
toxic
effect
biomass
fuel
consumpt
billion
expos
outdoor
air
pollut
billion
expos
tobacco
smoke
offici
report
health
societi
show
year
million
peopl
die
prematur
chronic
respiratori
diseas
european
respiratori
societi
public
offic
clinic
studi
demonstr
preciou
advantag
inhal
aerosol
system
therapi
therapeut
treatment
lung
disord
borghardt
et
al
inhal
rout
administr
chosen
effect
deliv
differ
type
prevent
reliev
drug
patient
airway
obstruct
own
uniqu
advantag
deliv
rel
small
dose
drug
directli
respiratori
tract
airway
achiev
high
local
concentr
diminish
system
advers
effect
besid
may
provid
consider
cost
save
lower
dosag
regimen
especi
expens
therapeut
agent
consequ
result
high
therapeut
ratio
compar
system
drug
deliveri
either
oral
parenter
rout
administr
borghardt
et
al
numer
countless
studi
shown
lung
provid
substanti
superior
bioavail
ba
macromolecul
rout
drug
deliveri
system
circul
paranjp
llergoymann
javadzadeh
yaqoubi
howev
understand
mechan
inhal
particl
deposit
within
respiratori
system
open
techniqu
ahead
deliv
drug
particl
directli
system
deposit
exert
anticip
action
achiev
develop
pharmaceut
dosag
form
known
aerosol
abl
aerosol
dosag
form
design
spray
mouth
caus
content
expel
contain
directli
lung
deposit
employ
anticip
action
aerosol
contain
activ
pharmaceut
ingredi
api
combin
addit
excipi
form
fine
mist
form
final
dosag
ingredi
packag
aid
pressur
form
pressur
dispens
call
aerosol
contain
excipi
therefor
compon
aerosol
contain
along
plenti
factor
account
aerosol
dosag
form
indic
optimum
function
thu
variou
qualiti
control
test
perform
dosag
form
guarante
ultim
product
optimum
perform
highest
safeti
fulfil
product
specif
go
discuss
detail
throughout
chapter
sahab
et
al
conclus
compar
rout
administr
inhal
drug
backbon
treatment
care
pulmonari
diseas
offer
signific
benefit
includ
target
drug
deliveri
reduc
system
side
effect
rapid
onset
action
combin
high
longterm
pulmonari
ba
achiev
benefit
sever
consider
bear
mind
regard
physiochem
properti
inhal
drug
formul
devic
characterist
comprehens
understand
lung
anatomi
patholog
along
associ
kinet
process
lung
dose
mechan
respiratori
particl
deposit
necessari
achiev
efficaci
inhal
drug
recent
decad
modern
medicin
advanc
concern
respiratori
disord
treatment
one
effici
drugdeliveri
techniqu
treatment
inhal
therapi
use
aerosol
dosag
form
allow
effect
deliveri
therapeut
activ
medica
respiratori
tract
understand
fundament
aspect
aerosol
dosag
form
provid
backbon
develop
techniqu
pharmaceut
aerosol
product
contain
therapeut
activ
ingredi
pack
pressur
previous
releas
upon
activ
appropri
actuat
valv
system
term
aerosol
origin
accustom
describ
liquid
solid
fine
mist
particl
specif
size
rang
term
aerosol
refer
pressur
pack
product
contain
activ
ingredi
excipi
dispers
liquefi
compress
ga
known
propel
power
propel
content
aerosol
expel
contain
uspnf
aerosol
dosag
form
topic
oral
nasal
system
inhal
incorpor
mani
differ
api
aerosol
use
treatment
wide
rang
diseas
acn
asthma
lung
infect
ashurst
et
al
exampl
salbutamol
metaproterenol
sulfat
administ
mean
inhal
aerosol
reliev
asthma
symptom
labiri
dolovich
fig
show
salbutamol
inhal
dispens
use
asthma
treatment
use
aerosol
dosag
form
wide
speedili
accept
patient
physician
numer
advantag
possess
dosag
form
follow
apiousbirlea
et
al
releas
accur
dose
erad
contamin
remain
materi
expand
stabil
content
advers
affect
oxid
moistur
direct
deliveri
medic
affect
area
desir
rate
form
spray
stream
foam
elimin
irrit
produc
topic
applic
topic
medic
aerosol
packag
consist
propel
product
concentr
contain
valv
actuat
shown
fig
propel
account
gener
proper
expel
pressur
within
contain
basic
product
concentr
aerosol
activ
drug
combin
suitabl
excipi
deliv
three
form
liquid
form
solut
suspens
emuls
form
similar
semisolid
contain
product
concentr
fill
valv
part
packag
product
concentr
expel
desir
form
rate
actuat
integr
part
everi
aerosol
packag
allow
easi
open
close
valv
usual
design
appropri
way
give
desir
form
discharg
fine
mist
liquid
stream
spray
coars
spray
etc
apiousbirlea
et
al
newman
liquefi
gase
use
stay
form
gase
ambient
atmospher
pressur
temperatur
elev
pressur
lower
temperatur
boil
point
liquefi
liquefi
gase
pack
seal
contain
chang
liquid
vapor
phase
pressur
insid
pressur
aerosol
contain
gradual
increas
throughout
format
vapor
phase
establish
equilibrium
liquefi
propel
phase
vapor
phase
liquid
content
aerosol
push
valv
action
pressur
upon
releas
valv
liquid
expel
come
contact
room
temperatur
atmospher
pressur
thu
caus
liquefi
propel
reappear
back
vapor
state
leav
compon
deposit
surfac
suppos
function
upon
exampl
liquefi
propel
fluorocarbon
includ
dichlorodifluoromethan
dichlorotetrafluoroethan
usual
util
oral
aerosol
wherea
qualiti
control
test
evalu
pharmaceut
aerosol
compress
ga
use
propel
gase
nitrogen
carbon
dioxid
chemic
consid
inert
ga
compress
aerosol
contain
due
expans
ga
power
push
content
contain
establish
singl
mixtur
propel
use
aerosol
dosag
form
lachman
lieberman
peter
floyd
et
al
aerosol
contain
manufactur
variabl
materi
coat
metal
glass
infrequ
plastic
contain
engin
deliv
good
stabil
efficaci
differ
product
formul
product
perform
prospect
characterist
product
formul
type
amount
propel
use
pressur
aerosol
content
even
compon
aerosol
manipul
alter
characterist
dispens
yield
perform
claim
label
lachman
lieberman
remington
allen
aerosol
valv
import
part
aerosol
contain
vital
part
respons
expel
dispens
desir
dose
aerosol
content
desir
control
rate
valv
account
deliv
product
concentr
prefer
form
control
flow
rate
content
contain
one
import
point
consid
manufactur
process
valv
resist
corros
withstand
intern
pressur
encount
due
byproduct
concentr
contain
aerosol
valv
also
respons
provid
appropri
amount
medic
import
especi
deliveri
potent
therapi
proper
dispers
purpos
valv
usual
spray
mg
liquid
materi
one
time
use
valv
johnchadwick
lachman
lieberman
remington
allen
deliveri
aerosol
content
depend
integr
function
provid
valv
assembl
propel
product
concentr
contain
actuat
aerosol
valv
uniqu
featur
dosag
vital
part
effect
expel
dispens
desir
dose
aerosol
content
control
rate
variou
type
aerosol
valv
use
depend
physic
form
dispens
aerosol
use
type
valv
variabl
mainli
two
type
applicableeith
continu
spray
valv
meter
valv
continu
spray
valv
deliv
product
content
constantli
form
spray
solid
foam
stream
without
amount
determin
kind
valv
main
type
use
categori
pharmaceut
aerosol
meter
valv
deliv
content
potent
medic
dispens
exact
amount
medica
upon
time
activ
applic
basic
part
valv
assembl
given
fig
describ
follow
lashkar
push
knob
user
press
activ
deactiv
assembl
valv
system
physic
form
emit
product
concentr
determin
combin
type
amount
propel
use
along
proper
actuat
design
dimens
stem
provid
necessari
support
actuat
deliv
content
desir
form
chamber
actuat
serv
prevent
leakag
product
concentr
valv
deactiv
posit
place
tightli
stem
spring
part
devic
allow
actuat
draw
backup
releas
pressur
return
valv
assembl
close
posit
way
besid
seal
gasket
place
prevent
outflow
formul
normal
mount
top
aerosol
contain
serv
hold
valv
place
featur
crimp
closur
open
contain
undersign
side
mount
cup
expos
formul
impos
consider
inner
part
contain
respect
meet
criteria
compat
necessari
may
coat
prevent
undesir
interact
hous
posit
directli
mount
cup
provid
associ
dip
tube
part
valv
stem
along
actuat
stem
collabor
hous
orific
help
control
deliveri
rate
determin
form
content
product
emit
dip
tube
part
valv
assembl
extend
downstream
product
concentr
aid
transport
content
contain
valv
inner
integr
dimens
dip
tube
hous
particular
product
determin
accord
viscos
product
intend
deliveri
rate
fig
show
basic
compon
valv
assembl
content
lashkar
aerosol
particl
direct
respiratori
tract
oral
nasal
rout
administr
end
respiratori
tract
inhal
particl
entir
reach
lung
exampl
one
administ
pump
mdi
includ
million
numer
inhal
particl
part
particl
deposit
intend
target
site
respiratori
tract
besid
inhal
particl
exhal
akira
et
al
consequ
formul
challeng
issu
order
accomplish
adequ
therapeut
respons
deliv
correct
desir
amount
drug
reach
lung
usmani
et
al
order
design
conveni
effect
safe
aerosol
devic
necessari
consid
mani
factor
consider
role
determin
quantiti
drug
get
transport
deposit
within
lung
factor
includ
aerosol
properti
shape
densiti
size
inhal
particl
mode
inhal
along
inhal
pattern
volum
inhal
flow
rate
along
breathhold
time
characterist
inhal
carrier
ga
factor
patientrel
factor
pathophysiolog
factor
along
type
sever
lung
diseas
chantal
kim
prisk
start
mean
oper
distribut
medic
particl
within
lung
superfici
greater
inhal
volum
meanwhil
inhal
flow
rate
increas
deposit
drug
oropharynx
larg
central
airway
impact
greater
lastli
achiev
adequ
drug
particl
deposit
mechan
gravit
particl
sediment
peripher
part
lung
breathhold
time
critic
factor
predict
aerosol
properti
especi
aerodynam
diamet
signific
import
come
deposit
drug
particl
lung
reliabl
particl
larger
diamet
get
deposit
oropharynx
larg
conduct
airway
particl
size
pharmaceut
aerosol
formul
heterodispers
mean
compos
variou
size
aerosol
element
mass
smaller
mass
median
aerodynam
diamet
mmad
particl
larger
mmad
ideal
size
pharmaceut
aerosol
particl
yet
welldefin
gener
known
order
inhal
particl
pass
bronchial
tree
mmad
exceed
particl
size
aerosol
could
determin
use
measurementrel
devic
cascad
impactor
laser
light
scatter
inhal
incom
air
undergo
seri
direct
chang
flow
nose
mouth
branch
airway
system
lung
structur
good
understand
mechan
inhal
particl
deposit
respiratori
tract
great
worth
assist
toxicolog
risk
inhal
improv
effici
drug
deliveri
manner
discuss
inhal
therapi
carvalho
et
al
gener
deposit
particl
within
respiratori
tract
depend
five
multipl
mechan
inerti
particl
impact
gravit
sediment
electrostat
precipit
intercept
brownian
particl
diffus
shown
fig
tu
et
al
inerti
impact
mechan
deposit
occur
airflow
chang
direct
particl
happen
close
airway
wall
follow
origin
direct
instead
adjust
airflow
particl
bigger
size
influenc
deposit
mechan
inertia
larg
aerosol
particl
led
increas
resist
chang
direct
flow
air
respiratori
tract
chang
path
suddenli
caus
deviat
away
streamlin
air
caus
impact
deposit
wall
airway
energi
particl
tend
keep
preestablish
path
time
air
chang
direct
airway
lead
high
propens
impact
airway
surfac
result
particl
near
airway
surfac
undergo
deposit
term
inerti
impact
possibl
deposit
impact
subject
ratio
particl
arrest
distanc
dimens
respiratori
airway
airstream
predict
veloc
tena
casan
type
deposit
mechan
particl
also
reliant
locat
particl
within
airway
highest
prospect
deposit
impact
respiratori
zone
mean
impact
foremost
concern
larg
respiratori
airway
exampl
bifurc
human
bronchial
tree
deposit
possibl
inhal
much
higher
element
move
along
middl
line
parent
tube
element
move
nearer
track
wall
like
deposit
locat
near
carina
bifurc
edg
cartilag
trachea
occur
two
main
bronchi
divis
highest
degre
deposit
impact
occur
throat
lesser
extent
bifurc
koullapi
et
al
higher
particl
mass
mobil
difficult
particl
adjust
curv
air
stream
larg
particl
tend
stick
origin
path
higher
relax
time
compar
small
particl
use
stoke
stk
number
paramet
character
particl
move
deviat
deposit
particl
increas
increas
flow
rate
along
growth
particl
mass
shown
eq
tena
casan
stk
uc
c
particl
densiti
particl
diamet
u
flow
veloc
c
c
slip
correct
factor
dynam
viscos
carrier
ga
airway
diamet
stk
number
show
probabl
particl
deposit
due
impact
directli
proport
flow
veloc
particl
densiti
diamet
wherea
invers
proport
airway
diamet
distanc
surfac
thu
deposit
mean
inerti
impact
signific
larger
particl
move
high
rate
close
surfac
diamet
particl
approach
magnitud
mean
free
path
air
molecul
particl
experi
slip
surfac
error
becom
signific
element
less
slip
correct
factor
insert
deposit
equat
correct
error
greater
stk
greater
probabl
inhal
particl
get
impact
follow
streamlin
air
get
deposit
airway
wall
inerti
impact
mechan
nicola
zaki
gravit
sediment
aerosol
particl
fall
size
rang
enter
respiratori
system
settl
princip
alveolar
caviti
small
airway
effect
graviti
settl
sediment
graviti
make
particl
leav
origin
air
stream
particl
sediment
settl
distanc
equal
termin
settl
veloc
vt
time
resid
time
airway
section
order
express
vt
eq
use
g
acceler
graviti
particl
densiti
diamet
particl
cc
slip
correct
factor
viscos
air
accord
probabl
particl
deposit
due
gravit
settl
directli
proport
densiti
particl
size
besid
resid
time
particl
contrast
inertia
invers
proport
air
stream
veloc
resid
time
decreas
increas
veloc
particl
deposit
mechan
therefor
substanti
smaller
airway
ga
exchang
region
air
veloc
low
maximum
remov
outcom
airway
surfac
come
close
horizont
configur
case
alveolar
region
tena
casan
gravit
sediment
signific
mechan
particl
deposit
microns
particl
small
airway
abl
pass
nasopharynx
larg
conduct
respiratori
airway
akira
et
al
brownian
diffus
manner
deposit
particl
smaller
diamet
deposit
result
aerosol
particl
strike
air
molecul
result
random
motion
aerosol
particl
inflict
deposit
within
area
airway
wherev
veloc
air
low
acinar
region
unlik
inerti
impact
gravit
sedimentdeposit
mechan
increas
particl
size
reduc
deposit
particl
brownian
diffus
thu
order
enhanc
deposit
particl
mechan
particl
size
reduc
manner
deposit
explain
diffus
coeffici
aerosol
particl
given
equat
eq
tena
casan
diffus
consider
mechan
deposit
submicron
particl
pulmonari
acinu
small
airway
contrast
settl
impact
deposit
approach
diffus
invers
proport
particl
diamet
control
geometr
size
rather
aerodynam
size
akira
et
al
k
b
boltzmann
constant
temperatur
particl
diamet
c
c
slip
correct
factor
air
viscos
intercept
result
contact
physic
particl
surfac
airway
surfac
physic
diamet
case
observ
particl
move
airway
narrow
width
particl
diamet
result
physic
contact
particl
airway
surfac
geometr
featur
probabl
deposit
intercept
depend
close
air
streamlin
airway
surfac
ratio
particl
diamet
airway
width
usual
small
even
smallest
airway
intercept
gener
less
signific
deposit
mechan
usual
import
mostli
fibrou
particl
tena
casan
akira
et
al
particl
deposit
electrostat
precipit
mechan
account
less
entir
deposit
respiratori
tract
mechan
import
electr
charg
particl
deposit
larg
number
share
charg
particl
drive
toward
airway
wall
absenc
collect
repuls
forc
charg
particl
also
attract
neutral
surfac
imag
forc
precipit
imag
forc
creat
electr
charg
particl
equal
opposit
charg
charg
opposit
imag
respiratori
tract
airway
surfac
frequent
conduct
electr
charg
electr
charg
particl
attract
toward
airway
wall
electrostat
lead
higher
deposit
rate
compar
neutral
particl
tena
casan
mutual
deposit
concern
inhal
molecul
throughout
region
respiratori
system
identifi
measur
experiment
measur
concentr
inhal
exhal
monodispers
regard
aerosol
test
control
condit
certain
calcul
produc
output
recogn
total
deposit
fraction
df
indic
total
fraction
aerosol
particl
inhal
deposit
among
differ
respiratori
region
consid
simplest
extens
appli
measur
mutual
deposit
inhal
particl
ndahl
et
al
total
df
identifi
respiratori
tract
deposit
particl
dose
rate
state
total
amount
inhal
element
number
mass
etc
deposit
airway
period
time
eg
lgmin
infer
doser
calcul
c
inhal
eg
particl
concentr
inhal
air
exposur
level
amount
particl
per
volum
air
mv
minut
ventil
min
paramet
df
least
avail
factor
depend
numer
paramet
respiratori
paramet
rate
rout
volum
subjectspecif
morpholog
lung
well
particl
size
shape
densiti
chemic
composit
oversight
df
doser
calcul
often
done
result
consider
uncertainti
factor
df
may
vari
less
almost
mainli
depend
particl
size
icrp
aerodynam
diamet
aerosol
element
larger
fraction
deposit
increas
lower
breath
frequenc
turn
provid
enough
extra
time
permit
increas
graviti
settl
particl
aerodynam
diamet
larger
deposit
increas
averag
airflow
rate
rise
type
particl
inerti
impact
deposit
mechan
affect
depend
veloc
tu
et
al
inhal
particl
size
rang
exhibit
minimum
mobil
diffus
impact
sediment
mechan
effect
carri
deposit
particl
physiolog
factor
influenc
respiratori
particl
deposit
includ
frequenc
breath
breathingapproach
pattern
pathway
breath
whether
oral
nasal
featur
ventil
airflow
dynam
tidal
lung
volum
displac
air
volum
normal
inhal
exhal
function
residu
capac
residu
amount
ga
left
lung
normal
exhal
increas
air
flow
rate
rais
outcom
effect
effect
velocityreli
particl
deposit
impact
mechan
decreas
effect
effect
timereli
particl
deposit
diffus
sediment
mechan
increas
tidal
lung
volum
permit
particl
reach
distribut
distal
respiratori
aeri
like
main
particl
deposit
govern
sediment
diffus
therefor
total
input
overal
deposit
compar
deposit
impact
increas
exercis
tidal
volum
breath
flow
rate
increas
result
increas
deposit
sediment
diffus
small
respiratori
airway
alveoli
hand
condit
increas
particl
impact
larg
airway
final
mouth
breather
result
particl
deposit
respiratori
tract
nose
breather
nasal
effici
particl
filter
compar
oral
rout
sankhal
et
al
anatom
factor
also
play
signific
role
particl
deposit
factor
respiratori
airway
length
diamet
alveolar
size
bronchiol
branch
angl
great
number
variat
total
respiratori
particl
deposit
among
normal
healthi
subject
breath
pattern
inter
subject
variabl
even
within
individu
age
patholog
process
along
chang
dimens
featur
tracheobronchi
tree
respiratori
system
lung
volum
gender
differ
anatom
respiratori
system
structur
modul
lung
function
also
caus
variat
deposit
men
women
exampl
deposit
lung
tracheobronchi
tree
higher
women
compar
men
averag
femal
thorax
dimens
smaller
men
lower
conduct
airway
volum
around
men
far
anatom
gender
volum
varianc
share
lesser
rest
minut
ventil
volum
volum
ga
inhal
volum
exhal
breath
flow
rate
pragmat
women
total
respiratori
particl
deposit
lesser
women
men
mainli
reason
smaller
dispers
aerosol
occur
alveolar
distal
region
femal
lung
respiratori
airway
breath
condit
geometri
develop
birth
matur
chang
affect
respiratori
element
deposit
childhood
accord
studi
particl
deposit
among
children
respiratori
particl
deposit
children
tend
higher
compar
adult
averag
factor
minor
lung
surfac
area
adult
quantiti
particl
deposit
per
surfac
area
higher
factor
children
sankhal
et
al
final
environment
factor
rel
humid
temperatur
graviti
prospect
impact
particl
deposit
studi
respiratori
function
done
absenc
graviti
parabol
flight
shown
disproportion
reduc
deposit
particl
size
rang
mm
compar
deposit
normal
graviti
hand
studi
also
suggest
particl
deposit
reduc
absenc
graviti
particl
peripher
deposit
lung
enhanc
compar
normal
graviti
ambient
rel
humid
significantli
affect
hygroscop
particl
growth
therefor
enhanc
deposit
effici
sankhal
et
al
order
achiev
desir
therapeut
action
pharmaceut
aerosol
particl
deposit
definit
region
respiratori
tract
certainli
target
receptor
present
bind
exert
therapeut
consequ
cheng
investig
studi
measur
ultim
total
deposit
region
deposit
within
lung
signific
evalu
potenti
hazard
inhal
element
assess
effect
dose
critic
site
within
lung
valu
deposit
respiratori
region
depend
effect
deposit
region
along
deposit
preced
region
exampl
deposit
respiratori
region
head
airway
tracheobronchi
region
essenti
import
sinc
provid
protect
vital
section
alveolar
region
harm
irrit
particl
sever
aspect
govern
deposit
particl
head
airway
region
breath
path
whether
mouth
nose
breath
flow
rate
inhal
particl
size
inhal
air
pass
nasal
caviti
humidifi
warm
filter
princip
particl
filter
impact
settl
nasal
hair
curvatur
path
airflow
mouth
breath
inspiratori
lmin
flow
rate
nearli
aerodynam
diamet
particl
proport
rang
deposit
formerli
inhal
air
reach
larynx
inhal
air
inhal
mouth
nose
deposit
head
airway
increas
averag
inspiratori
flow
rate
rise
meanwhil
airborn
micro
ultrafin
particl
less
substanti
deposit
surfac
head
airway
due
great
diffus
coeffici
cheng
usual
alveolar
deposit
determin
measur
proport
inspir
particl
pass
head
airway
region
ultim
deposit
alveolar
region
proport
deposit
alveolar
region
influenc
breath
rate
tidal
volum
particl
size
consid
mutual
caus
size
discriminatori
particl
deposit
tracheobronchi
region
declin
number
particl
size
rang
reach
alveolar
region
particl
larger
fail
reach
alveolar
region
tu
et
al
understand
physic
chemic
particl
properti
particl
size
influenc
region
particl
deposit
respiratori
tract
key
issu
achiev
desir
effect
pharmaceut
aerosol
order
confirm
function
reproduc
stabil
aerosol
pharmaceut
formul
function
perform
form
system
predetermin
way
aid
necessari
analyt
techniqu
need
term
mutual
relationship
pharmaceut
develop
manufactur
regulatori
entiti
continu
develop
requir
meet
challeng
ensur
efficaci
qualiti
safeti
new
technolog
global
marketplac
ultim
respons
qualiti
therapi
medic
devic
lie
sever
nation
intern
regulatori
bodi
elect
safeguard
public
health
copley
scientif
qualiti
key
issu
within
pharmaceut
industri
part
good
manufactur
practic
ensur
essenti
appropri
test
actual
carri
product
releas
sale
suppli
consequ
human
use
qualiti
arbitr
satisfactori
accord
specif
qualiti
control
issu
concern
repres
sampl
provis
specif
test
along
organ
certif
releas
procedur
eudralex
uddin
et
al
guidelin
procedur
standard
qualiti
control
test
pharmaceut
aerosol
describ
differ
pharmacopeia
regulatori
affair
compar
standard
oper
test
procedur
aerosol
differ
refer
pharmacopeia
show
minor
chang
differ
test
limit
guidelin
vari
countri
countri
harmon
standard
specif
possibl
univers
definit
approv
procedur
measur
accept
criteria
region
teja
et
al
addit
pharmacopoeia
regulatori
bodi
european
pharmaceut
aerosol
group
epag
intern
pharmaceut
aerosol
consortium
regul
scienc
scientif
investig
standard
regul
oper
test
procedur
aerosol
product
includ
clinic
aspect
appropri
figur
consensu
contribut
toward
oper
regul
standard
share
consequ
research
via
technic
journal
scientif
pharmaceut
confer
discuss
negoti
regulatori
bodi
aim
creat
coordin
scientif
base
good
practic
provid
consensu
refer
industri
government
agenc
order
improv
safeti
qualiti
standard
recommend
harmon
standard
methodolog
inprocess
qualiti
control
finish
product
qualiti
control
pharmaceut
aerosol
among
drug
product
exampl
pharmaceut
aerosol
inprocess
qualiti
control
ipqc
finish
product
qualiti
control
fpqc
must
maintain
demand
qualiti
control
test
ensur
proper
activ
ingredi
pressur
packag
perform
along
safeti
use
storag
could
ensur
test
mention
pharmacopeia
pharmaceut
aerosol
must
strictli
perform
ensur
proper
qualiti
therefor
human
health
safeti
certifi
pharmaceut
aerosol
indian
pharmacopoeia
british
pharmacopoeia
commiss
us
pharmacopeia
total
qualiti
product
assur
ipqc
fpqc
test
total
qualiti
process
ipqc
fpqc
test
repres
rigor
test
allow
product
complet
indefect
launch
market
uddin
et
al
mani
concern
need
measur
order
obtain
product
appropri
qualiti
depend
requir
nation
author
legisl
manufactur
intern
polici
product
process
safeti
market
etc
pharmaceut
aerosol
qualiti
evalu
depend
sever
test
perform
throughout
formul
develop
process
finish
product
inspect
phase
zhu
et
al
qualitycontrol
test
standard
guid
principl
pharmaceut
aerosol
obtain
pharmacopeia
regul
associ
british
pharmacopoeia
unit
state
pharmacopoeia
nation
formulari
uspnf
intern
pharmacopoeia
intern
pharmaceut
aerosol
consortium
regul
scienc
associ
epag
uddin
et
al
ipqc
test
carri
regular
interv
process
product
manufactur
complet
purpos
ipqc
monitor
assess
qualiti
pharmaceut
product
evalu
carri
necessari
product
adapt
manufactur
process
compli
pharmacopeia
fpqc
test
perform
complet
manufactur
process
purpos
evalu
qualit
quantit
featur
finish
product
well
ass
test
procedur
accept
paramet
obey
finish
pharmaceut
product
throughout
valid
shelf
life
teja
et
al
accord
refer
regulatori
gridlin
follow
evalu
test
must
perform
drive
purpos
test
elimin
pure
propel
dip
tube
well
concentr
addit
inspect
defect
valv
spray
pattern
kadam
et
al
test
method
encompass
imping
test
spray
surfac
treat
piec
paper
dyetalc
mixtur
shown
fig
natur
aerosol
determin
whether
watersolubl
oilsolubl
dye
appli
spray
particl
strike
surfac
substrat
test
paper
caus
dye
convert
solut
absorb
onto
paper
outcom
test
give
highlight
record
spray
design
latterli
use
compar
assess
eventu
give
spray
pattern
record
pharmaceut
carri
batch
inspect
mean
entir
whole
aerosol
within
batch
spray
test
conclud
record
use
compar
differ
batch
meter
dose
aerosol
spray
pattern
aerosol
great
effect
dose
medic
reach
patient
lung
gardenhir
et
al
leak
test
done
check
crimp
aerosol
dispens
valv
must
avail
avoid
defect
contain
accomplish
determin
crimp
measur
ensur
dimens
meet
specif
evalu
test
involv
allow
fill
contain
pass
water
bath
final
test
valv
closur
done
bestow
test
leakag
defin
weight
chang
contain
store
vertic
posit
c
c
minimum
day
accord
uspnf
pressur
contain
select
random
aerosol
dispens
select
weigh
mg
consid
weight
posit
allow
fill
test
contain
stand
upright
correct
posit
room
temperatur
least
day
weigh
contain
determin
find
weight
mg
contain
time
contain
test
determin
hour
ultim
leakag
rate
contain
calcul
mgyear
follow
leakag
rate
meet
standard
requir
averag
leakag
rate
sampl
contain
less
net
fill
weight
per
year
necessari
test
contain
none
leak
net
fill
weight
per
year
one
contain
leak
per
year
none
contain
leak
per
year
necessari
determin
leakag
rate
addit
contain
ultim
accord
requir
contain
leak
net
fill
weight
per
year
lachman
lieberman
uspnf
assess
procedur
check
accuraci
fill
procedur
assur
uniform
final
total
weight
product
tare
empti
contain
ad
concentr
fill
line
subsequ
remov
later
patch
weigh
order
investig
fit
requir
measur
uspnf
weight
check
done
period
addit
empti
aerosol
contain
fill
line
remov
later
fill
product
concentr
weigh
techniqu
usual
use
check
weight
propel
assess
finish
product
fill
contain
weigh
check
accuraci
fill
oper
unit
test
express
pound
ounc
pokar
et
al
test
mean
ensur
valv
procur
technic
accept
sourc
valv
foundat
oper
unit
must
perform
requir
valv
problem
caus
lost
product
previou
studi
perform
reveal
valv
failur
caus
inadequ
design
defici
materi
attribut
valv
design
oper
difficulti
excess
seat
leakag
extern
leakag
valv
type
accept
test
need
test
valv
design
limit
temperatur
pressur
valv
accept
test
procedur
appli
two
categori
meter
aerosol
valv
follow
limit
deliveri
less
limit
deliveri
limit
four
aerosol
valv
outsid
limit
specifi
valv
deliveri
valv
reject
three
individu
dispensari
outsid
limit
test
repeat
use
anoth
new
sampl
valv
patch
accept
one
valv
deliveri
outsid
specif
otherwis
lot
reject
anoth
valv
test
lachman
lieberman
variou
materi
use
contain
tinplat
aluminum
stainless
steel
certain
type
glass
one
import
criteria
select
aerosol
contain
withstood
intern
creat
pressur
high
psi
f
remington
allen
coat
uncoat
contain
evalu
defect
inner
line
quit
lot
qualiti
control
aspect
assess
paramet
appli
accord
type
contain
use
metal
qualitycontrol
aspect
includ
specif
extent
electr
current
conduct
quantit
measur
expos
metal
glass
contain
inspect
crack
defect
weak
contain
common
paramet
evalu
part
measur
weight
guarante
fulfil
specif
obligatori
dimens
contain
necklin
construct
part
must
check
determin
conform
specif
apiousbirlea
et
al
numer
physic
chemic
inquiri
appli
aerosol
receptacl
fragment
sever
step
support
document
review
object
test
measur
averag
magnitud
valv
deliveri
degre
uniform
discret
valv
twentyf
valv
sampl
batch
chosen
use
sampl
plan
index
accept
qualiti
level
militari
sampl
method
receptacl
full
standard
test
solut
defin
specif
graviti
propos
assess
variat
valv
deliveri
solut
alcohol
uspnf
isopropyl
myrist
dichlorodifluoromethan
trichloromonofluoromethan
c
subsequ
actuat
mount
valv
fill
contain
locat
c
c
airspac
chang
temperatur
fill
receptacl
actuat
fullest
extent
least
second
weigh
differ
determin
weight
repres
deliveri
mg
test
repeat
least
twice
unit
sampl
unit
final
rate
valv
deliveri
per
actuat
calcul
microlit
apiousbirlea
et
al
uddin
et
al
valv
rate
deliveri
rate
per
actuat
individu
deliveri
weight
mg
specif
graviti
test
solut
purpos
test
identifi
work
composit
mixtur
exist
blend
propel
appli
see
whether
match
label
test
carri
perform
ir
spectrophotometri
ga
chromatographi
inspect
vapor
pressur
determin
moistur
content
densiti
nonvolatil
residu
halogen
determin
sign
puriti
satisfactori
propel
apiousbirlea
et
al
uspnf
pharmaceut
aerosol
must
satisfi
certain
standard
claim
qualiti
therapeut
perform
drug
mandatori
maintain
qualiti
varieg
number
evalu
base
seri
test
carri
formul
develop
finish
product
test
stage
base
pharmacopeia
standard
specif
presenc
propel
uniqu
featur
dosag
whose
properti
flash
point
subject
qualiti
control
evalu
ensur
proper
aerosol
perform
safeti
pharmaceut
aerosol
test
evalu
order
ensur
satisfactori
perform
appropri
safeti
packag
store
use
thu
certain
biolog
physic
chemic
paramet
test
evalu
aerosolsthes
test
discuss
detail
section
base
type
amount
ingredi
certain
pharmaceut
aerosol
compris
flammabl
propel
hydrocarbon
propel
typic
order
guarante
safeti
product
prior
patient
use
storag
transport
flammabl
combust
aerosol
evalu
numer
test
protocol
quantifi
degre
flammabl
combust
base
intern
standard
flammabl
combust
determin
upcom
procedur
remington
allen
flash
point
temperatur
measur
propens
test
concentr
sampl
form
flammabl
blend
air
control
defin
laboratori
condit
signific
flash
point
determin
use
determin
correct
condit
storag
ship
state
safeti
regul
flammabl
combust
materi
order
determin
flash
point
aerosol
two
basic
apparatu
type
avail
open
cup
close
cup
shown
fig
close
cup
test
purpos
simul
situat
fluid
spill
close
environment
condit
liquid
test
sampl
flash
point
fire
explos
possibl
expos
possibl
ignit
sourc
close
cup
test
determin
flash
point
investig
sampl
place
insid
seal
test
cup
introduc
potenti
ignit
sourc
determin
temperatur
sampl
flash
open
cup
apparatu
use
standard
label
lashkar
flash
point
test
protocol
done
cool
temperatur
aerosol
product
almost
f
aerosol
captiv
test
apparatu
gradual
start
increas
temperatur
test
liquid
lowest
temperatur
vapor
ignit
record
temperatur
flash
point
test
liquid
obtain
flash
point
typic
refer
flammabl
compon
flash
point
parmar
patel
one
point
known
open
cup
apparatu
constantli
give
higher
flash
point
close
cup
one
open
cup
permit
loss
intern
vapor
atmospher
apparatu
consequ
close
cup
assess
usual
specifi
owe
improv
precis
felton
type
evalu
test
also
acknowledg
flame
project
test
test
therapeut
activ
aerosol
includ
similar
test
evalu
therapeut
activ
nonaerosol
pharmaceut
dosag
form
case
aerosol
also
relat
associ
particl
size
spread
primari
step
dosag
inhal
aerosol
must
determin
sure
prior
test
therapeut
activ
inhal
aerosol
topic
aerosol
therapeut
activ
determin
topic
appli
therapeut
activ
ingredi
directli
test
area
evalu
amount
therapeut
activ
substanc
absorb
lashkar
remington
allen
chemic
physic
characterist
aerosol
determin
atmospher
remov
gravit
settl
diffusion
growth
extent
water
absorpt
lead
size
growth
subsequ
elimin
wet
dri
deposit
signific
aerosol
size
growth
constitu
chemic
composit
determin
atmospher
lifetim
stress
basic
chemic
physic
properti
aerosol
includ
follow
measur
evalu
total
vapor
pressur
aerosol
contain
could
achiev
use
special
equip
pressur
gaug
water
bath
test
gaug
determin
pressur
variat
differ
patch
contain
essenti
import
variat
extrem
indic
air
present
within
dispens
headspac
could
affect
stabil
product
measur
vapor
pressur
accur
punctur
devic
use
parmar
patel
use
differ
instrument
hydromet
pycnomet
rel
densiti
aerosol
liquid
determin
initi
choke
valv
glass
pressur
tube
metal
flang
fit
togeth
permit
liquid
pressur
introduc
hydromet
posit
within
glass
pressur
tube
sampl
introduc
valv
caus
rise
hydromet
halfway
tube
length
directli
densiti
read
densiti
gener
express
gml
parmar
patel
chromatographi
karl
fischer
method
two
mani
method
demonstr
use
evalu
moistur
content
aerosol
contain
usual
moistur
content
express
percentag
karl
fischer
method
precis
techniqu
determin
moistur
specif
water
content
use
karl
fischer
reagent
interact
select
quantit
water
find
moistur
content
karl
fischer
reagent
consist
basic
solut
sulfur
dioxid
iodin
solvent
alcohol
remington
allen
lachman
lieberman
base
result
seen
stabil
studi
limit
moistur
content
establish
emea
european
medicin
agenc
inspect
discuss
previous
two
main
devic
use
evalu
propel
infrar
ir
spectrophotometri
ga
chromatographi
method
correspondingli
use
indic
compon
proport
theori
practic
industri
pharmaci
lachman
lieberman
label
fill
volum
base
liquefi
propel
concentr
volum
determin
concentr
volum
propel
volum
headspac
volum
empti
volum
upper
portion
dispens
specifi
temperatur
usual
densiti
concentr
propel
use
tu
et
al
evalu
aerosol
two
main
consider
measur
first
function
improv
patientrequir
complianc
minim
lost
improv
eas
use
sever
test
includ
evalu
predict
aerosol
respir
good
perform
evalu
test
discuss
detail
section
second
consider
capabl
contain
system
deliv
accur
amount
requir
rate
fda
albert
discharg
ratio
aerosol
valv
fine
measur
quantiti
expel
materi
dispens
valv
given
time
interv
identifi
weight
standard
apparatu
use
time
interv
pass
aerosol
contain
reweight
discharg
ratio
defin
gram
per
second
normal
discharg
durat
second
test
conduct
control
temperatur
achiev
good
reproduc
usual
test
repeat
three
time
give
three
determin
parmar
patel
consid
good
packag
system
function
minim
wast
fill
aerosol
contain
contain
test
leakag
mean
suitabl
advanc
detector
use
halogen
compound
detector
automat
instantan
detect
reject
leak
contain
grante
optim
oper
offici
compendi
specif
usp
xxinf
usual
appli
order
gravimetr
determin
leakag
rate
certain
group
contain
follow
offici
norm
aulton
taylor
mani
type
advanc
method
use
find
aerosol
particl
size
cascad
impactor
light
scatter
decay
approach
wide
use
method
among
anoth
measur
mass
median
diamet
solid
aerosol
particl
cascad
impact
devic
classifi
particl
droplet
present
sampl
aerosol
base
particl
aerodynam
diamet
though
seri
glass
slide
nozzl
project
highveloc
stream
particl
impactor
classifi
particl
known
size
rang
power
air
jet
devic
nozzl
impact
flat
sampl
surfac
phase
collect
finer
size
particl
predecessor
larg
particl
impact
collect
first
plane
stage
lower
veloc
small
particl
pass
get
collect
stage
higher
veloc
particl
adequ
inertia
impact
relat
particular
stage
collect
plate
whilst
finer
particl
stay
entrain
air
stream
move
next
stage
process
repeat
lashkar
fig
illustr
cascad
impactor
light
scatter
decay
base
principl
aerosol
settl
turbul
condit
stage
particl
size
determin
chang
tindal
beam
light
intens
unit
particl
size
express
micromet
mitchel
nagel
accord
formul
foam
lifetim
limit
second
known
quick
break
foam
foam
persist
hour
differ
method
appli
order
evalu
stabil
foam
releas
aerosol
contain
includ
use
rotat
viscomet
visual
evalu
foam
time
determin
specifi
mass
penetr
foam
also
time
given
rod
fall
place
foam
could
use
lachman
lieberman
net
content
net
weight
statement
specifi
much
avail
product
contain
indic
whether
aerosol
contain
fill
suffici
could
estim
use
sever
method
one
method
empti
aerosol
contain
weight
prior
fill
contain
reweight
process
fill
seal
conduct
differ
weight
consid
net
content
parmar
patel
evalu
procedur
import
order
compar
differ
valv
materi
spray
pattern
assess
reli
spray
content
contain
rotat
paper
impregn
dye
solut
color
spot
produc
homogen
color
indic
homogen
spray
pattern
aim
behind
rotat
control
amount
materi
come
contact
paper
depend
formul
natur
type
dye
use
piec
revolv
paper
could
dyetalc
mixtur
watersolubl
dye
oilsolubl
dye
spray
content
spray
allow
collid
piec
paper
particl
come
contact
dye
chang
solut
get
absorb
onto
rotat
paper
give
record
spray
pattern
use
comparison
differ
pattern
among
contain
lachman
lieberman
multipl
point
must
taken
consider
evalu
dose
deliv
valv
first
confeder
dosag
emit
time
depress
valv
reproduc
test
one
two
method
either
dispens
one
two
dose
valv
pressur
mdi
contain
recoveri
solut
solvent
absorb
activ
ingredi
formula
assay
materi
amount
activ
ingredi
found
method
use
evalu
dosag
emit
valv
accur
weight
fill
contain
sever
dose
dispens
follow
reweight
contain
time
averag
dose
emit
valv
found
divid
differ
weight
number
dispens
dose
second
import
confeder
much
medic
patient
actual
receiv
quit
difficult
evalu
vitro
success
matter
achiev
use
artifici
humanlik
respiratori
system
newman
sever
test
includ
evalu
predict
variou
factor
relat
aerosol
good
perform
actuat
tube
design
moistur
content
vapor
pressur
propel
spray
pattern
effici
valv
crimp
measur
particl
size
aerosol
varieti
techniqu
employ
univers
branch
aerosol
perform
test
qualit
confirm
assess
also
known
ident
test
appli
verifi
type
pharmaceut
activ
ingredi
claim
found
pharmaceut
aerosol
hand
test
also
use
differenti
compon
similar
close
relat
structur
might
exist
formula
identif
test
specif
drug
substanc
eg
ir
spectroscopi
highperform
liquid
chromatographyultraviolet
spectrophotomet
hplcuv
hplcmass
spectrometri
hplcm
ga
chromatographymass
spectrometri
gcm
gener
accept
jr
allen
uddin
et
al
uddin
et
al
quantit
activ
ingredi
ident
test
also
known
content
test
use
determin
strength
content
pharmaceut
activ
ingredi
aerosol
use
ultraviolet
spectrophotomet
absorb
determin
ml
spray
solut
taken
adequ
dilut
concentr
determin
standard
plot
drug
content
calcul
percentag
theoret
valu
parmar
patel
actual
drug
content
theoret
drug
content
amount
drug
substanc
determin
per
weight
unit
per
volum
unit
multidos
product
usual
assay
limit
medicin
product
appli
emea
european
medicin
agenc
inspect
character
potenti
impur
degrad
product
may
result
degrad
activ
ingredi
manufactur
storag
result
new
drug
synthesi
import
requir
aerosol
safeti
evalu
jr
allen
uddin
et
al
uddin
et
al
sever
method
applic
issu
hplc
ga
chromatographi
one
innov
detector
charg
aerosol
detect
technolog
deliv
good
perform
measur
analyt
charg
direct
proport
amount
analyt
present
zhang
et
al
specif
appear
describ
pharmaceut
aerosol
drug
product
qualit
uddin
et
al
aerosol
specifi
descript
formul
includ
activ
ingredi
excipi
along
complet
deliveri
devic
charact
eg
descript
specif
might
read
red
cap
blue
bodi
linear
actuat
specifi
nebul
product
instantan
packag
defin
eg
transluc
opaqu
lowdens
polyethylen
nebula
emea
european
medicin
agenc
inspect
success
prepar
packag
pharmaceut
aerosol
requir
certain
knowledg
skill
equip
pharmaceut
product
process
must
carri
strict
supervis
observ
rigid
qualitycontrol
requir
food
drug
administr
fda
guidanc
document
requir
assess
main
four
attribut
establish
suitabl
protect
drugdeliveri
perform
safeti
compat
four
attribut
must
evalu
prove
desir
concern
aerosol
product
perform
drug
product
signifi
contain
closur
system
appropri
essenti
defin
qualiti
control
measur
use
ensur
physic
chemic
composit
consist
packag
compon
qualiti
compon
eventu
contain
closur
system
monitor
use
simpl
test
physic
consider
evalu
seal
integr
determin
water
vapor
transmiss
monitor
melt
point
glass
transit
plastic
use
differenti
scan
colorimetri
thermal
analysi
ir
scan
verifi
ident
part
ongo
monitor
qualitycontrol
program
dimension
criteria
defin
monitor
volum
shape
thick
barrier
design
toler
evalu
chemic
composit
also
consid
via
simpl
inform
uspnf
physicochem
test
use
water
drug
product
vehicl
alcohol
extract
plastic
compon
satisfi
standard
minim
risk
grante
effect
product
releas
appropri
desir
rate
fda
albert
specif
modif
qualitycontrol
system
must
carri
sinc
part
manufactur
oper
addit
propel
concentr
carri
packag
oper
special
equip
capabl
handl
pack
formula
high
pressur
rel
low
temperatur
f
must
avail
addit
equip
use
compound
liquid
suspens
emuls
cream
ointment
equip
usual
limit
aerosol
pressur
packag
instanc
use
pharmaceut
oper
lachman
lieberman
aulton
taylor
lightresist
contain
propos
offer
protect
light
evalu
perform
uspnf
light
transmiss
test
evalu
procedur
necessit
use
precis
sensit
spectrophotomet
alter
determin
quantiti
light
transmit
contain
materi
especi
plastic
contain
also
perform
carri
uspnf
water
vapor
permeat
test
capabl
contain
closur
system
protect
transmiss
moistur
could
evalu
uspnf
set
limit
amount
moistur
migrat
packag
system
base
upon
size
composit
packag
materi
especi
plastic
contain
uspnf
contain
compon
compat
dosag
form
must
ascertain
ensur
qualiti
drug
compon
evalu
natur
andor
amount
chemic
permeat
packag
materi
drug
product
realiz
leachabl
studi
design
purpos
sever
sensit
analyt
procedur
method
applic
determin
liquid
chromatographymass
spectrometri
gcm
ir
scan
evalu
nonvolatil
organ
quantit
inorgan
element
provid
proof
ident
leachabl
studi
assess
materi
migrat
vehicl
length
product
shelf
life
claim
regular
time
interv
month
year
extent
shelf
life
claim
met
chang
may
caus
degrad
drug
product
ph
shift
precipit
discolor
evalu
along
assist
physic
stabil
contain
evalu
chang
characterist
brittl
use
thermal
detector
analysi
method
hard
test
norwood
et
al
defin
safeti
packag
compon
simpl
process
standard
techniqu
recogn
howev
packag
compon
made
constitu
leach
toxic
disagre
quantiti
constitu
patient
drug
treatment
chief
consider
extract
isol
studi
accomplish
incub
contain
sampl
differ
solvent
definit
wellcontrol
temperatur
time
interv
contain
use
pack
medic
classifi
high
degre
concern
inhal
aerosol
know
degrad
product
may
releas
drug
product
signific
prior
perform
evalu
chemic
test
discuss
import
accur
descript
inform
synthesi
procedur
appli
solvent
use
procedur
besid
know
differ
addit
ad
product
manufactur
uspnf
includ
physicochem
test
evalu
contain
materi
applic
sensit
quick
cheap
help
set
contain
materi
safeti
offici
test
state
uspnf
base
water
extract
alcohol
nonpolar
solvent
precis
temperatur
time
limit
gener
test
mainli
valu
determin
materi
high
low
extract
chemic
besid
classifi
materi
extract
comprehens
term
total
extract
nonvolatil
deposit
heavymet
content
residu
ignit
turbid
buffer
capac
albert
uspnf
estim
safeti
also
involv
analyt
method
instrument
recogn
qualiti
quantiti
extract
chemic
collect
suffici
inform
allow
identif
potenti
toxic
hazard
result
chemic
compon
packag
materi
hplc
gasliquid
hplc
glc
respect
influenti
analyt
apparatus
identifi
separ
estim
quantiti
volatil
nonvolatil
chemic
mass
spectrum
import
analyt
method
provid
fragment
pattern
molecul
make
excel
adequ
tool
recogn
degrad
product
unknown
impur
biolog
reactiv
anoth
part
contain
safeti
test
design
test
toxicolog
properti
extract
chemic
uspnf
biolog
reactiv
test
measur
give
limit
safe
level
exposur
provid
good
evalu
toxicolog
properti
mean
label
specifi
rout
administr
albert
consid
evalu
main
attribut
prepar
packag
pharmaceut
aerosol
along
evalu
result
stabil
test
larg
concern
success
aerosol
product
perform
shelf
life
total
qualiti
use
guidelin
intern
council
harmon
technic
requir
pharmaceut
human
use
ich
guidelin
worldwid
nonprofit
organ
underneath
swiss
law
mission
achiev
better
univers
harmon
guarante
effect
highqual
safe
therapeut
drug
organ
gather
pharmaceut
manufactur
regulatori
author
investig
discuss
scientif
technic
aspect
drug
registr
one
import
aspect
medicin
stabil
test
test
inspect
environment
influenc
drug
constitu
finish
product
consider
time
ultim
evalu
result
stabil
test
assess
relat
total
qualiti
translat
appropri
recommend
storag
condit
shelf
life
product
guidelin
stabil
test
condit
chosen
reliant
understand
impact
climat
condit
region
european
countri
unit
state
japan
order
condens
amount
stabil
test
requir
world
divid
four
climat
zone
purpos
worldwid
stabil
test
follow
zone
temper
zone
ii
subtrop
like
high
humid
zone
iii
hot
dri
zone
iv
hothumid
ich
harmonis
tripartit
guidelin
two
type
stabil
evalu
protocol
electrochem
test
longterm
static
test
electrochem
test
protocol
provid
effect
screen
tool
limit
concern
amount
stabil
data
obtain
longterm
static
test
gener
perform
temperatur
f
period
month
year
type
stabil
test
provid
import
stabil
data
weight
loss
physic
chemic
chang
concentratepropel
satur
fluctuat
vapor
pressur
measur
maintain
origin
spray
characterist
corros
concentr
stabil
parmar
patel
four
categori
ich
topic
code
assign
efficaci
safeti
qualiti
multidisciplinari
guidelin
guidelin
focus
certain
field
test
legisl
efficaci
guidelin
specifi
studi
evalu
relationship
dose
system
level
along
therapeut
respons
develop
new
drug
safeti
guidelin
relat
vitro
vivo
preclin
studi
carcinogen
genotox
test
stabil
guidelin
finish
pharmaceut
product
aerosol
describ
sever
arrang
titl
ensur
standard
practic
storag
aerosol
stabil
evalu
new
drug
substanc
finish
product
defin
recommend
stabil
test
protocol
climat
zone
ii
includ
temperatur
rel
humid
trial
durat
consid
requir
stabil
test
climat
zone
iii
iv
minim
differ
storag
condit
submiss
global
registr
ich
harmonis
tripartit
guidelin
qualiti
guidelin
account
conduct
stabil
studi
defin
relev
impur
test
differ
approach
relat
ensur
pharmaceut
qualiti
base
manag
risk
toward
good
manufactur
practic
also
guidelin
provid
recommend
applic
plan
product
qualiti
studi
measur
pharmacokinet
pk
ba
andor
establish
bioequival
estim
pk
inhal
drug
essenti
import
defin
drug
concentrationtim
profil
respiratori
lung
tissu
site
intend
action
predict
describ
efficaci
human
inhal
drug
also
provid
inform
valuabl
determin
ba
estim
lung
disposit
kinet
paramet
inhal
therapi
return
help
enhanc
lung
deliveri
drug
simultan
pk
studi
use
mean
explain
system
advers
effect
occur
system
aerosol
inhal
mouth
borghardt
et
al
physiolog
base
pk
compartment
noncompartment
method
use
find
pk
paramet
inhal
drug
hand
incorpor
physiolog
base
pk
mathemat
model
relat
disposit
respons
given
inhal
drug
obtain
jessi
shaikh
widespread
avail
sensit
assay
method
highperform
liquid
chromatographi
allow
estim
plasma
urinari
drug
level
requir
pk
evalu
allow
precis
reproduc
quantif
drug
deliveri
determin
plasma
level
reflect
effect
lung
absorpt
borghardt
et
al
administr
perspect
order
guarante
predict
clinic
outcom
ie
efficaci
safeti
medic
therapi
dosag
form
clinic
trial
drug
certain
data
inform
follow
ba
studi
ba
studi
relat
estim
rate
extent
api
absorb
system
dosag
form
drug
product
becom
avail
exert
intend
therapeut
effect
target
site
action
certain
drug
dosag
form
propos
absorb
system
ba
may
measur
base
select
pk
measur
reflect
rate
extent
api
becom
avail
employ
desir
therapeut
effect
intend
site
action
lungdeliv
therapi
pk
paramet
assess
convent
titl
role
quantif
drug
deliveri
lung
provid
signific
data
respiratorymed
aerosol
ba
complementari
supplementari
techniqu
radiolabel
deposit
borghardt
et
al
productqu
studi
compar
characterist
differ
pharmaceut
altern
defin
absenc
signific
varianc
ident
potenc
qualiti
rate
extent
api
reach
site
drug
action
administ
equival
molar
dose
similar
control
condit
compar
pharmaceut
altern
properli
design
studi
studi
import
develop
approv
gener
new
drug
compar
clinic
trial
materi
offici
refer
list
drug
establish
ba
vitro
vivo
studi
use
use
vivo
pk
pharmacodynam
pd
clinic
case
vitro
studi
use
alon
chen
et
al
ba
assess
type
aerosol
local
act
nasal
aerosol
spray
complic
drug
deliveri
target
site
action
occur
princip
system
absorpt
although
drug
administ
nasal
local
action
potenti
yield
system
activ
even
though
plasma
level
gener
reflect
amount
drug
reach
nasal
site
action
reason
ba
studi
gener
would
consid
local
deliveri
system
exposur
system
absorpt
fda
complic
areol
featur
dosag
form
render
difficult
mimic
climb
challeng
question
regard
similar
type
properti
essenti
control
order
guarante
efficaci
qualiti
product
differ
aspect
shown
predict
correl
relev
consider
radiolabel
imag
deposit
aerosol
deposit
imag
expand
vitro
perform
product
influenc
breath
pattern
deposit
predict
model
deposit
apiousbirlea
et
al
concept
vitro
impli
biolog
consider
similar
perform
two
product
use
concern
exert
suffici
control
key
properti
known
correl
therapeut
effect
achiev
breath
pattern
lung
deposit
two
inhal
product
show
pulmonari
similar
dose
deliv
deposit
lung
drug
enter
target
pulmonari
cell
rate
product
also
deliv
drug
intend
central
peripher
part
lung
azarmi
et
al
us
depart
human
health
servic
fda
formal
guidanc
inhal
product
howev
fda
publish
outlin
requir
clinic
document
oral
inhal
drug
product
foundat
element
approach
qualit
quantit
formul
devic
same
relat
physicochem
composit
properti
formul
compon
oper
devic
similar
level
underpin
vitro
vivo
perform
lee
et
al
variou
advanc
pharmaceut
aerosol
drug
deliveri
system
wit
technolog
devic
formul
applic
pulmonari
drug
deliveri
system
inhal
pulmonari
approach
therapeut
drug
deliveri
increasingli
attract
attent
explor
medicin
target
system
diseasesit
longer
preserv
respiratori
drug
simon
moor
size
market
respiratori
inhal
devic
continu
expand
estim
suggest
reach
billion
end
compound
annual
growth
simon
moor
nanotechnolog
need
special
mention
discuss
futur
uniqu
develop
pharmaceut
product
nanotechnolog
develop
innov
inhal
particl
engin
techniqu
enabl
full
potenti
control
physic
particl
chrematist
size
shape
surfacerel
properti
agglomer
state
along
chemistri
inhal
particl
enhanc
formul
uniqu
dosag
form
improv
drug
deliveri
pulmonari
system
market
nanotechnolog
usag
medicin
drug
deliveri
system
emerg
innov
promis
applic
prevent
diagnosi
treatment
predict
total
global
amount
spend
nanotech
enabl
drug
deliveri
therapeut
market
around
billion
would
repres
nanomedicin
global
moghimi
et
al
advanc
pharmaceut
healthcar
industri
contribut
drug
develop
order
meet
demand
effect
way
fight
differ
diseas
led
develop
countless
effect
therapeut
drug
deliveri
methodspharmaceut
inhal
aerosol
one
success
prepar
packag
pharmaceut
aerosol
requir
certain
knowledg
skill
equip
pharmaceut
product
process
must
carri
strict
supervis
observ
rigid
qualitycontrol
requir
qualiti
pharmaceut
aerosol
key
issu
within
pharmaceut
industri
pressur
dosag
form
ipqc
fpqc
must
maintain
rigor
qualiti
control
test
ensur
appropri
perform
packag
activ
ingredi
guarante
safeti
storag
use
per
specif
respect
pharmacopeia
regulatori
requir
particular
countri
differ
studi
clearli
reveal
variou
pharmacopeia
suggest
differ
type
ipqc
fpqc
test
pharmaceut
aerosol
differ
specif
standard
main
function
pharmacopeia
assur
maximum
qualiti
pharmaceut
human
health
establish
harmon
standard
methodolog
regul
oper
test
procedur
aerosol
product
recommend
addit
pharmacopeia
regulatori
bodi
consid
evalu
main
four
attribut
prepar
packag
pharmaceut
aerosol
protect
drug
deliveri
perform
safeti
compat
along
evalu
result
stabil
test
larg
concern
success
aerosol
product
perform
high
total
qualiti
use
estim
appropri
recommend
storag
condit
shelf
life
product
find
pk
paramet
inhal
drug
physiolog
base
pk
compartment
noncompartment
method
use
order
guarante
predict
clinic
outcom
ie
efficaci
safeti
medic
therapi
dosag
form
clinic
trial
drug
certain
data
inform
follow
ba
studi
use
vivo
pk
pd
clinic
case
vitro
studi
use
alon
complic
areol
featur
make
assess
ba
type
aerosol
local
act
nasal
aerosol
spray
difficult
differ
aspect
shown
predict
correl
relev
consider
radiolabel
imag
deposit
aerosol
deposit
imag
expand
vitro
perform
product
influenc
breath
pattern
deposit
predict
model
deposit
